查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571566

免疫沉澱市場規模、佔有率和趨勢分析報告：按產品類型、最終用途、地區和細分市場預測，2024-2030 年

Immunoprecipitation Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

免疫沉澱市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球免疫沉澱市場規模預計將達到 11 億美元。

預計2024年至2030年該市場將以5.7%的複合年成長率成長。生命科學領域的成長預計將推動市場。免疫沉澱技術的技術進步也導致了高需求。

免疫沉澱分析法透過將抗體與蛋白質結合，使目標蛋白質從溶液中沉澱出來。該技術可以從大量不同的蛋白質樣本中分離和富集特定蛋白質或蛋白質複合物。生命科學產業的成長主要是由主要企業對研發領域的大量投資所推動的。 2016年，默克研發投入約2.868億美元，支援2,000多種產品的上市。

蛋白質精製方法新產品的推出導致市場快速成長。例如，2016年，賽默飛世爾科技公司宣布了一種使用免疫沉澱-質譜技術的新抗體測試和檢驗方法。它的開發是為了幫助抗體製造商、研究人員和其他客戶識別適合蛋白質分析的抗體。各種套件和試劑（例如抗體、珠子和緩衝液）的可用性預計將顯著增加該技術的使用。

免疫沉澱市場報告亮點

  • 試劑產品領域在免疫沉澱市場佔據主導地位，2023年銷售佔有率為53.9%。試劑部分以抗體為主，廣泛應用於各種免疫沉澱技術。
  • 個別蛋白質免疫沉澱類型主導免疫沉澱市場，2023 年收益佔有率為 28.6%。
  • 在研發投資以及政府津貼、捐贈和私人組織資金不斷增加的推動下，學術和研究機構細分市場在免疫沉澱市場佔據主導地位，2023 年收益佔有率為 45.1%。
  • 北美免疫沉澱市場主導全球免疫沉澱市場，2023年收益佔有率為36.7%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章免疫沉澱市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 免疫沉澱市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 免疫沉澱市場：產品評估與趨勢分析

  • 細分儀表板
  • 免疫沉澱市場：2023 年和 2030 年產品變異分析
  • 套件
  • 試劑

第5章免疫沉澱市場：類型估計和趨勢分析

  • 細分儀表板
  • 免疫沉澱市場：類型變異分析，2023 年和 2030 年
  • 個體蛋白免疫沉澱
  • 蛋白質複合物免疫沉澱
  • 染色質免疫沉澱
  • 核糖核蛋白免疫沉澱分析法
  • 標記蛋白的免疫沉澱

第6章免疫沉澱市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 免疫沉澱市場：2023 年和 2030 年最終用途變化分析
  • 學術研究所
  • 製藥和生物技術公司
  • 委託研究組織

第7章免疫沉澱市場：區域估計與趨勢分析

  • 2023 年及 2030 年免疫沉澱市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Abcam Limited
    • BioLegend, Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript
    • Merck KGaA
    • Novus Biologicals
    • Takara Bio Inc.
    • Biologics International Corp
簡介目錄
Product Code: GVR-4-68038-017-0

Immunoprecipitation Market Growth & Trends:

The global immunoprecipitation market size is anticipated to reach USD 1.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2024 to 2030. Growth of the life science sector is expected to drive the market. Technological advancements in immunoprecipitation techniques is another factor contributing to high demand.

Immunoprecipitation helps precipitate target protein from a solution by binding an antibody to that protein. This technique allows isolation and concentration of a particular protein or protein complex out of a sample of numerous different proteins. Growth in the life science industry is rising mainly due to significant investments made in the R&D sector by key players. In 2016, Merck invested around USD 286.8 million in R&D, which supported their launch of over 2,000 products.

Introduction of novel products in protein purification methods has led to rapid growth in the market. For instance, in 2016, Thermo Fisher Scientific introduced a new antibody testing and verification methodology by using Immunoprecipitation-Mass Spectrometry technique. This is developed in order to assist antibody manufacturers, researchers, and other customers in identifying a suitable antibody for protein analysis. Availability of varied kits and reagents, such as antibodies, beads, and buffers is expected to increase the adoption of this technique to a great extent.

Immunoprecipitation Market Report Highlights:

  • The reagents product segment dominated the immunoprecipitation market with a revenue share of 53.9% in 2023. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques.
  • The individual protein immunoprecipitation type segment dominated the immunoprecipitation market with a revenue share of 28.6% in 2023.
  • The academic & research institutes segment dominated the immunoprecipitation market with a revenue share of 45.1% in 2023, fueled by increased R&D investments and funding from government grants, donations, and private organizations.
  • North America immunoprecipitation market dominated the global immunoprecipitation market with a revenue share of 36.7% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoprecipitation Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunoprecipitation Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoprecipitation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunoprecipitation Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antibodies
      • 4.4.2.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Beads
      • 4.4.3.1. Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoprecipitation Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunoprecipitation Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Individual Protein Immunoprecipitation
    • 5.3.1. Individual Protein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Protein Complex Immunoprecipitation
    • 5.4.1. Protein Complex Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Chromatin Immunoprecipitation
    • 5.5.1. Chromatin Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Ribonucleoprotein Immunoprecipitation
    • 5.6.1. Ribonucleoprotein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tagged Proteins Immunoprecipitation
    • 5.7.1. Tagged Proteins Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoprecipitation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunoprecipitation Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Contract Research Organizations
    • 6.5.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoprecipitation Market: Regional Estimates & Trend Analysis

  • 7.1. Immunoprecipitation Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/Strategic Initiatives
    • 8.4.2. Abcam Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/Strategic Initiatives
    • 8.4.3. BioLegend, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/Strategic Initiatives
    • 8.4.5. GenScript
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/Strategic Initiatives
    • 8.4.6. Merck KGaA
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/Strategic Initiatives
    • 8.4.7. Novus Biologicals
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/Strategic Initiatives
    • 8.4.8. Takara Bio Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/Strategic Initiatives
    • 8.4.9. Biologics International Corp
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/Strategic Initiatives